Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Qihan Biotech
company
About
Qihan Biotech is a gene-editing organ transplantation technology developer.
- 251 - 500
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $7.80M
- Industries
- Biotechnology,Clinical Trials,Health Care,Medical,Medical Device
- Founded date
- Jan 1, 2017
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Qihan Biotech is a biomedical company based on genetic technology. Kaixin Bio ’s mission is to create a new world where patients do n’t have to wait for organ transplants. We are committed to using the world's advanced gene editing technology to produce safe and effective cells, tissues and organs that can be used for human transplantation, and to solve the serious shortage of organ transplant donors in China and the world.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$100.30M
Qihan Biotech has raised a total of
$100.30M
in funding over 2 rounds. Their latest funding was raised on
Mar 29, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 29, 2021 | Series A | $67M | 1 |
Lilly Asia Ventures
|
— | Detail |
| Sep 22, 2019 | Series A | $25.50M | 1 | — | — | Detail |
| Jul 23, 2018 | Series A | $7.80M | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Qihan Biotech has made 1 investments. Their most recent investment was on
Aug 19, 2019, when ResortPass raised $9M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Aug 19, 2019
ResortPass
|
Series A | $9M | Hospitality | — |
Investors
Number of Lead Investors
Number of Investors
1
3
Qihan Biotech is funded by 3 investors.
Lilly Asia Ventures
and Xinyi Biology
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Lilly Asia Ventures
|
Yes | Series A |
|
|
— | Series A |
ARCH Venture Partners
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
